LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 72 filers reported holding LOXO ONCOLOGY INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $605,000 | +34.1% | 4,322 | +63.8% | 0.10% | +119.1% |
| Q3 2018 | $451,000 | -42.7% | 2,638 | -41.8% | 0.05% | -93.2% |
| Q2 2018 | $787,000 | -27.0% | 4,535 | -51.5% | 0.70% | -25.6% |
| Q1 2018 | $1,078,000 | +189.8% | 9,346 | +111.3% | 0.94% | +100.2% |
| Q4 2017 | $372,000 | -8.6% | 4,424 | +0.2% | 0.47% | +749.1% |
| Q3 2017 | $407,000 | +26.8% | 4,413 | +10.1% | 0.06% | +14.6% |
| Q2 2017 | $321,000 | -26.7% | 4,009 | -61.5% | 0.05% | -38.5% |
| Q1 2017 | $438,000 | +45.0% | 10,408 | +10.6% | 0.08% | -13.3% |
| Q4 2016 | $302,000 | +12.7% | 9,411 | -8.0% | 0.09% | -30.8% |
| Q3 2016 | $268,000 | +13.1% | 10,231 | 0.0% | 0.13% | -26.1% |
| Q2 2016 | $237,000 | -0.4% | 10,231 | +17.4% | 0.18% | -46.3% |
| Q1 2016 | $238,000 | -9.5% | 8,712 | -5.9% | 0.33% | -54.6% |
| Q4 2015 | $263,000 | – | 9,258 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 4,028,920 | $129,409,000 | 30.09% |
| Casdin Capital, LLC | 360,000 | $11,561,000 | 9.55% |
| DAFNA Capital Management LLC | 139,722 | $4,487,000 | 3.94% |
| Opaleye Management Inc. | 125,000 | $4,014,000 | 2.36% |
| Eventide Asset Management | 740,000 | $23,765,000 | 1.55% |
| Crawford Lake Capital Management, LLC | 52,713 | $1,693,000 | 1.22% |
| AWM Investment Company, Inc. | 180,000 | $5,781,000 | 1.13% |
| Orbimed Advisors | 1,728,000 | $55,495,000 | 0.71% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 423,276 | $13,594,000 | 0.48% |
| EAM Investors, LLC | 111,268 | $3,573,000 | 0.48% |